B-FLEXION FUND MANAGEMENT (IRELAND) LIMITED

B‑FLEXION Fund Management (Ireland) Limited is a private, entrepreneurial investment firm that partners with sophisticated capital to create lasting value for investors while making a positive contribution to society. Drawing on a heritage that began as a three‑generation biopharmaceutical company, B‑FLEXION now operates a diversified portfolio of asset managers and direct operating businesses across Europe and the United States.

The group’s specialisations span life‑sciences, real‑estate and specialty‑therapy sectors. Recent highlights include B‑FLEXION Life Sciences acquiring the remaining 57 % interest in Radius Health, the acquisition of Argyll – London’s premier serviced‑office provider – by its real‑estate partner Crosstree, and Paratek Pharmaceuticals’ purchase of Optinose to broaden its specialty‑therapy portfolio. Through these strategic moves, B‑FLEXION delivers growth‑oriented investment opportunities to sophisticated institutional and private investors.

People are at the heart of the organisation; attracting and developing top talent is described as its most important strategic imperative. By combining a long‑term, value‑focused investment approach with a commitment to its people and societal impact, B‑FLEXION serves capital partners seeking enduring, gener